Cynosure Group LLC Takes $366,000 Position in Addus HomeCare Co. (NASDAQ:ADUS)

Cynosure Group LLC acquired a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) in the 3rd quarter, HoldingsChannel reports. The firm acquired 2,754 shares of the company’s stock, valued at approximately $366,000.

Other institutional investors also recently bought and sold shares of the company. Texas Permanent School Fund Corp grew its stake in shares of Addus HomeCare by 0.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after buying an additional 82 shares during the period. Arizona State Retirement System grew its position in Addus HomeCare by 2.0% in the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after acquiring an additional 87 shares during the period. UMB Bank n.a. increased its stake in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the last quarter. Inspire Investing LLC raised its position in Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after purchasing an additional 100 shares during the period. Finally, New York State Teachers Retirement System lifted its stake in shares of Addus HomeCare by 1.2% in the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after purchasing an additional 100 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Trading Down 2.5 %

Shares of NASDAQ ADUS opened at $121.29 on Friday. Addus HomeCare Co. has a 12-month low of $85.43 and a 12-month high of $136.12. The stock has a market cap of $2.20 billion, a P/E ratio of 27.76, a PEG ratio of 2.15 and a beta of 1.04. The business’s fifty day simple moving average is $127.69 and its 200-day simple moving average is $123.50.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter last year, the business posted $1.03 EPS. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. On average, equities analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Oppenheimer raised their price objective on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Stephens boosted their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp began coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $131.63.

Insiders Place Their Bets

In related news, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares in the company, valued at approximately $429,165. This represents a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,500 shares of company stock worth $1,668,265 in the last 90 days. Corporate insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.